M Better - JoVE Visualize

Showing results (11-20 of 25) with videos related to

Pageof 3

Sort By:

Cell|December 1, 1983

Structural relationships among Rhizobium meliloti symbiotic promotersM Better, B Lewis, D Corbin, et al.

Science (New York, N.Y.)|May 20, 1988

Escherichia coli secretion of an active chimeric antibody fragmentM Better, C P Chang, R R Robinson, et al.

Human Antibodies and Hybridomas|April 11, 1991

Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activitiesR R Robinson, J Chartier, C P Chang, et al.

International Journal of Immunopharmacology|November 1, 1993

Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient miceF R Kohn, D M Fishwild, S L Bernhard, et al.

The Journal of Biological Chemistry|August 15, 1992

Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988

Secretion of functional antibody and Fab fragment from yeast cellsA H Horwitz, C P Chang, M Better, et al.

Protein Engineering|June 1, 1994

Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residuesG M Studnicka, S Soares, M Better, et al.

The Journal of Biological Chemistry|April 1, 1994

Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique propertiesM Better, S L Bernhard, D M Fishwild, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993

Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2M Better, S L Bernhard, S P Lei, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 15, 1991

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosisB L Kotzin, S Karuturi, Y K Chou, et al.

Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:

Pageof 3

Cell|December 1, 1983

Structural relationships among Rhizobium meliloti symbiotic promotersM Better, B Lewis, D Corbin, et al.

Science (New York, N.Y.)|May 20, 1988

Escherichia coli secretion of an active chimeric antibody fragmentM Better, C P Chang, R R Robinson, et al.

Human Antibodies and Hybridomas|April 11, 1991

Chimeric mouse-human anti-carcinoma antibodies that mediate different anti-tumor cell biological activitiesR R Robinson, J Chartier, C P Chang, et al.

International Journal of Immunopharmacology|November 1, 1993

Efficacy of anti-CD5 F(ab')2 and Fab' immunoconjugates in human peripheral blood lymphocyte-reconstituted severe combined immunodeficient miceF R Kohn, D M Fishwild, S L Bernhard, et al.

The Journal of Biological Chemistry|August 15, 1992

Activity of recombinant mitogillin and mitogillin immunoconjugatesM Better, S L Bernhard, S P Lei, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1988

Secretion of functional antibody and Fab fragment from yeast cellsA H Horwitz, C P Chang, M Better, et al.

Protein Engineering|June 1, 1994

Human-engineered monoclonal antibodies retain full specific binding activity by preserving non-CDR complementarity-modulating residuesG M Studnicka, S Soares, M Better, et al.

The Journal of Biological Chemistry|April 1, 1994

Gelonin analogs with engineered cysteine residues form antibody immunoconjugates with unique propertiesM Better, S L Bernhard, D M Fishwild, et al.

Proceedings of the National Academy of Sciences of the United States of America|January 15, 1993

Potent anti-CD5 ricin A chain immunoconjugates from bacterially produced Fab' and F(ab')2M Better, S L Bernhard, S P Lei, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 15, 1991

Preferential T-cell receptor beta-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosisB L Kotzin, S Karuturi, Y K Chou, et al.

Pageof 3